Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, recently SKI2VL was also shown to be essential for mouse development, with whole-body deletion leading to embryo lethality before embryonic day E13.5 (Yang et al. 2022).”
From DIS3L, cytoplasmic exosome catalytic subunit, is essential for development but not cell viability in mice. (2025) · cites this paper as Yang et al. 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 1×
“We also found that Skiv2l-deficient keratinocytes were substantially larger than control cells (Figure 4H and Supplemental Figure 7D), consistent with the notion that mTORC1 controls mammalian cell size by regulating protein translation (12).”
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 1×
“For instance, Aicardi-Goutières syndrome mutations in RNase H2 (cleaves RNA-DNA hybrids) or in adenosine deaminase acting on RNA 1 (ADAR1) invoke innate immune sensing of self-nucleic acids (DNA or RNA), leading to type I IFN signaling and systemic inflammation (13).”
BackgroundLai, Z., Hanczko, R., Bonilla, E., Caza, T. N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34502 · Cited by 428 · cited 2×
“Treatment with sirolimus, an mTORC1 inhibitor, corrects the proinflammatory T cell phenotype and improves clinical outcomes in patients with SLE (23, 26).”
BackgroundLai, Z.-W., Kelly, R., Winans, T., Marchena, I., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Tily, H., Francis, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30485-9 · Cited by 412 · cited 2×
“Treatment with sirolimus, an mTORC1 inhibitor, corrects the proinflammatory T cell phenotype and improves clinical outcomes in patients with SLE (23, 26).”
BackgroundThe Yeast Ski Complex: Crystal Structure and RNA Channeling to the Exosome Complex
Halbach, F., Reichelt, P., Rode, M., & Conti, E. (2013) · Cell · doi:10.1016/j.cell.2013.07.017 · Cited by 210
Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126091 · Cited by 147
Increased mTOR activation in idiopathic multicentric Castleman disease
Arenas, D. J., Floess, K., Kobrin, D., Pai, R.-A. L., Srkalovic, M. B., Tamakloe, M.-A., Rasheed, R., Ziglar, J., Khor, J., Parente, S. A. T., et al. (2020) · Blood · doi:10.1182/blood.2019002792 · Cited by 83
Research works printed but not linked: 32
- 10.1146/annurev-immunol-042718-041257 · DOI · Paper page
- 10.1089/jir.2016.0086 · DOI · Paper page
- 10.1038/ni.2948 · DOI · Paper page
- 10.1038/nrm1964 · DOI · Paper page
- 10.1038/nrm.2015.15 · DOI · Paper page
- 10.1126/science.aaf7520 · DOI · Paper page
- 10.1016/j.molcel.2020.01.011 · DOI · Paper page
- 10.1016/j.ajhg.2012.02.009 · DOI · Paper page
- 10.1053/j.gastro.2010.02.010 · DOI · Paper page
- 10.1002/humu.23418 · DOI
- 10.1016/j.molcel.2020.01.007 · DOI · Paper page
- 10.1038/s41586-018-0032-3 · DOI
- 10.1038/s41584-019-0272-0 · DOI · Paper page
- 10.1146/annurev-immunol-032713-120225 · DOI · Paper page
- 10.1016/j.coi.2017.10.003 · DOI
- 10.1038/83713 · DOI · Paper page
- 10.1136/archdischild-2013-304016 · DOI
- 10.1038/s41572-020-0204-y · DOI · Paper page
- 10.4049/jimmunol.0803600 · DOI · Paper page
- 10.4049/jimmunol.1301859 · DOI · Paper page
- 10.1038/nrrheum.2015.172 · DOI · Paper page
- 10.1182/blood-2015-11-685024 · DOI · Paper page
- Pai, 2020, Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease, JCI Insight, 5, 10.1172/jci.insight.135031 · DOI · Paper page
- 10.1111/j.1365-2141.2009.07595.x · DOI · Paper page
- 10.3324/haematol.2016.153411 · doi:10.3324/haematol.2016.153411
- 10.1016/j.gene.2019.02.059 · DOI
- 10.1172/JCI133264 · DOI · Paper page
- Quan, 2013, TSC1/2 regulates intestinal stem cell maintenance and lineage differentiation through Rheb-TORC1-S6K but independently of nutritional status or Notch regulation, J Cell Sci, 126, 3884
- 10.1172/JCI69751 · DOI · Paper page
- 10.1038/s41590-019-0569-9 · DOI · Paper page
- 10.1007/s10875-016-0359-1 · DOI · Paper page
- 10.1084/jem.20180783 · DOI · Paper page
Cited by
Tomecki, R., Drazkowska, K., Kobylecki, K., & Tudek, A. (2023) · WIREs RNA · doi:10.1002/wrna.1795 · Cited by 18
Brouze, M., Szpila, M., Czerwińska, A. M., Antczak, W., Mroczek, S., Kuliński, T., Hojka-Osińska, A. M., Cysewski, D., Gewartowska, O., Adamska, D., et al. (2025) · RNA · doi:10.1261/rna.080350.124 · Cited by 6
Metadata
- Authors
- Yang, K., Han, J., Asada, M., Gill, J. G., Park, J. Y., Sathe, M. N., Gattineni, J., Wright, T., Wysocki, C. A., de la Morena, M. T., Garza, L. A., & Yan, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2022-01-18
- Volume
- 132
- Issue
- 2
- ISSN
- 1558-8238
- Cited by
- 17
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.